Cargando…

Management issues with exogenous steroid therapy

Glucocorticoids (GCs) are extensively used for various inflammatory and autoimmune disorders, but long term use of these agents is not without complications. Almost every GC formulations (e.g. oral, topical, inhaled, etc.) can cause systemic side effects. It can range from minor side effects (e.g. w...

Descripción completa

Detalles Bibliográficos
Autores principales: Patt, Hiren, Bandgar, Tushar, Lila, Anurag, Shah, Nalini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046616/
https://www.ncbi.nlm.nih.gov/pubmed/24910822
http://dx.doi.org/10.4103/2230-8210.123548
_version_ 1782480287225085952
author Patt, Hiren
Bandgar, Tushar
Lila, Anurag
Shah, Nalini
author_facet Patt, Hiren
Bandgar, Tushar
Lila, Anurag
Shah, Nalini
author_sort Patt, Hiren
collection PubMed
description Glucocorticoids (GCs) are extensively used for various inflammatory and autoimmune disorders, but long term use of these agents is not without complications. Almost every GC formulations (e.g. oral, topical, inhaled, etc.) can cause systemic side effects. It can range from minor side effects (e.g. weight gain) to life-threatening effects (e.g. adrenal suppression, sepsis, etc.), which may require immediate intervention. Therefore, the decision to institute steroid therapy always requires careful consideration of the relative risk and benefit in each patient. The objectives of this study are to discuss monitoring of patients on GCs and management of the complications of GCs.
format Online
Article
Text
id pubmed-4046616
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-40466162014-06-06 Management issues with exogenous steroid therapy Patt, Hiren Bandgar, Tushar Lila, Anurag Shah, Nalini Indian J Endocrinol Metab Review Article Glucocorticoids (GCs) are extensively used for various inflammatory and autoimmune disorders, but long term use of these agents is not without complications. Almost every GC formulations (e.g. oral, topical, inhaled, etc.) can cause systemic side effects. It can range from minor side effects (e.g. weight gain) to life-threatening effects (e.g. adrenal suppression, sepsis, etc.), which may require immediate intervention. Therefore, the decision to institute steroid therapy always requires careful consideration of the relative risk and benefit in each patient. The objectives of this study are to discuss monitoring of patients on GCs and management of the complications of GCs. Medknow Publications & Media Pvt Ltd 2013-12 /pmc/articles/PMC4046616/ /pubmed/24910822 http://dx.doi.org/10.4103/2230-8210.123548 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Patt, Hiren
Bandgar, Tushar
Lila, Anurag
Shah, Nalini
Management issues with exogenous steroid therapy
title Management issues with exogenous steroid therapy
title_full Management issues with exogenous steroid therapy
title_fullStr Management issues with exogenous steroid therapy
title_full_unstemmed Management issues with exogenous steroid therapy
title_short Management issues with exogenous steroid therapy
title_sort management issues with exogenous steroid therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046616/
https://www.ncbi.nlm.nih.gov/pubmed/24910822
http://dx.doi.org/10.4103/2230-8210.123548
work_keys_str_mv AT patthiren managementissueswithexogenoussteroidtherapy
AT bandgartushar managementissueswithexogenoussteroidtherapy
AT lilaanurag managementissueswithexogenoussteroidtherapy
AT shahnalini managementissueswithexogenoussteroidtherapy